• Dimerix talks 18th annual Bioshares Biotech Summit

  • Jul 17 2024
  • Duración: 4 m
  • Podcast

Dimerix talks 18th annual Bioshares Biotech Summit

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Dimerix Ltd (ASX:DXB) CEO and managing director Dr Nina Webster is in the Proactive studio following the 18th annual Bioshares Biotech Summit in Perth. Dimerix is is a clinical stage biopharmaceutical company with a scalable, proprietary platform technology called Receptor-HIT. Incorporated in 2004, Dimerix develops and commercialises patient preferred pharmaceutical products for global markets using its innovative receptor technology to identify and develop drugs in areas with an unmet need. Dimerix has successfully used the Receptor-HIT technology to identify a novel treatment (DMX-200) that may transform the lives of patients with inflammatory diseases, such as kidney or lung diseases. Dimerix encourages collaboration and is well positioned to discuss partnering and product development. #ProactiveInvestors #Dimerix #ASX #DXB #Biotech #Bioshares #Summit #BiosharesBiotechSummit #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Más Menos
Empresas y Profesiones Economía Finanzas Personales Política y Gobierno
Más Menos

Lo que los oyentes dicen sobre Dimerix talks 18th annual Bioshares Biotech Summit

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles